Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Efstathiou

Showing results (261-270 of 273) with videos related to

Pageof 28
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerSeth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2025
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trialsA Dal Pra, P Ghadjar, H M Ryu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized TrialsTing Martin Ma, Yilun Sun, Shawn Malone, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyPhilippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
European Urology|August 7, 2022
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)Ting Martin Ma, Fang-I Chu, Howard Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the ProstateSoumyajit Roy, Tahmineh Romero, Jeff M Michalski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder CancerAndrea Necchi, Matthew D Galsky, Nazli Dizman, et al.
European Urology|April 26, 2022
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP ConsortiumAmar U Kishan, Xiaoyan Wang, Yilun Sun, et al.
Pageof 28

Showing results (261-270 of 273) with videos related to

Sort By:
Pageof 28
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerSeth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 22, 2025
Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trialsA Dal Pra, P Ghadjar, H M Ryu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2022
Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized TrialsTing Martin Ma, Yilun Sun, Shawn Malone, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyPhilippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 5, 2016
NCCN Guidelines Insights: Bladder Cancer, Version 2.2016Peter E Clark, Philippe E Spiess, Neeraj Agarwal, et al.
European Urology|August 7, 2022
Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)Ting Martin Ma, Fang-I Chu, Howard Sandler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2023
Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the ProstateSoumyajit Roy, Tahmineh Romero, Jeff M Michalski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2025
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder CancerAndrea Necchi, Matthew D Galsky, Nazli Dizman, et al.
European Urology|April 26, 2022
High-dose Radiotherapy or Androgen Deprivation Therapy (HEAT) as Treatment Intensification for Localized Prostate Cancer: An Individual Patient-data Network Meta-analysis from the MARCAP ConsortiumAmar U Kishan, Xiaoyan Wang, Yilun Sun, et al.
Pageof 28